BrainStorm Cell Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update ...Middle East

PR Newswire - News
BrainStorm Cell Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
Biologics License Application for NurOwn® for the treatment of ALS to be subject of an upcoming FDA Advisory Committee Meeting Conference call and webcast at 8:00 a.m. Eastern Time today NEW YORK, May 15, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading...

Hence then, the article about brainstorm cell therapeutics announces first quarter 2023 financial results and provides corporate update was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BrainStorm Cell Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update )

Apple Storegoogle play

Last updated :

Also on site :



Latest News